Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost ‐Effectiveness Analysis

ConclusionsWe find DBS would not be cost-effective in the short-term (one year) but may be cost-effective in longer timelines. Since DBS holds promise to potentially be a cost-effective treatment for CUDs, future randomized controlled trials should be performed to assess its efficacy.

Source: Neuromodulation: Technology at the Neural Interface - May 24, 2021 Category: Biotechnology Authors: Fiene Marie Kuijper, Uma V. Mahajan, Seul Ku, Daniel A. N. Barbosa, Sheila M. Alessi, Sherman C. Stein, Kyle M. Kampman, Brandon S. Bentzley, Casey H. Halpern Tags: Clinical Research Source Type: research